Stock Day Media

BioLargo’s CupriDyne Technology Proven Effective at Inactivating SARS-CoV-2

May 21, 2020May 21, 2020 Stock Day Media 744 Views BioLargo, CupriDyne, Inactivating, SARS-CoV-2, Technologyproven

WESTMINSTER, CA / ACCESSWIRE / May 21, 2020 / BioLargo, Inc. (OTCQB:BLGO), developer of sustainable technologies and a full-service environmental engineering

BioTech

Tauriga Sciences Inc. Taking Immediate Steps to Strengthen its Board of Directors and Corporate Governance Protocols With Aim Towards Future Up-List to a National Stock Exchange

January 15, 2021 Stock Day Media Comments Off

NEW YORK, NY, Jan. 15, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue

BioTech

CytRx Highlights Use of Aldoxorubicin in Phase 2 Clinical Trials Yielding Positive Interim Data on Survival Rates in Metastatic Pancreatic Cancer Patients

January 15, 2021 Stock Day Media Comments Off

BioTech

BioCorRx Announces Update on NIDA Grant and Development of Naltrexone Implant for the Treatment of Opioid and Alcohol Use Disorders

January 15, 2021 Stock Day Media Comments Off

Technology

Nextech AR Signs Poly Deal

January 15, 2021 Stock Day Media Comments Off